Company news

Elicio Therapeutics, Inc. news in 2026

Elicio Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

November 5, 2026

Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC

November 4, 2026

Elicio Therapeutics Presents Late-Breaking Phase 2 AMPLIFY-7P Results at ESMO Congress 2026 and Announces Simultaneous Publication in Nature Medicine

October 23, 2026

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

September 24, 2026

Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

August 31, 2026

Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

August 24, 2026

Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

August 13, 2026

Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma

August 10, 2026

Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering

July 6, 2026

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering

July 2, 2026

Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes

June 29, 2026

Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer

June 17, 2026

Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer

June 15, 2026

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

June 1, 2026

Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates

May 11, 2026

Elicio Therapeutics to Present at the Bank of America Healthcare Conference

April 30, 2026

Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

March 12, 2026

Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

February 25, 2026

Elicio Therapeutics Reports Inducement Grants

January 16, 2026

Decks in 2026